Clinical Trial Update: GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets [NA]

View source ↗

Summary

The GIANT trial completed evaluating the implementation of normoglycaemic targets in general practice in Asia for Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: International Diabetes Institute, Australia | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED